HomeInsightsResults

Jubilant Pharmova Ltd Quarterly Result

Jubilant Pharmova Ltd Quarterly Result

stocks purchased

₹ 0.9 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

7.9 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Jubilant Pharmova Ltd

NSE: JUBLPHARMA

Net Profit

₹ 102.5

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Jubilant Pharmova Ltd for the Sep '24 is ₹ 1774 crore as compare to the Jun '24 revenue of ₹ 2141 crore. This represent the decline of -17.16474%.
  • The ebitda of Jubilant Pharmova Ltd for the Sep '24 is ₹ 296.8 crore as compare to the Jun '24 ebitda of ₹ 661.4 crore. This represent the decline of -55.125496%.
  • The net profit of Jubilant Pharmova Ltd for the Sep '24 is ₹ 102.5 crore as compare to the Jun '24 net profit of ₹ 481.8 crore. This represent the decline of -78.72562%.

Results Analysis

Market Price of Jubilant Pharmova Ltd

1M

1Y

3Y

5Y

Monitoring Jubilant Pharmova Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241141.2
21 Nov 20241130.85
19 Nov 20241131.1
18 Nov 20241145.1
14 Nov 20241166.9
13 Nov 20241145.45
12 Nov 20241189.65
11 Nov 20241225.45
08 Nov 20241236.95
07 Nov 20241256.35

Historical Revenue of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical EBITDA of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Net Profit of Jubilant Pharmova Ltd

No data available

* All values are in crore

Jubilant Pharmova Ltd News Hub

News

Jubilant Pharmova to conduct board meeting

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 25 Octob...

Read more

18 Oct 202410:41

News

Jubilant Pharmova gains as Washington unit gets VAI classification from USFDA

The United States Food & Drug Administration (USFDA) conducted an audit of the facility fr...

Read more

11 Sep 202410:52

News

Jubilant Pharmova Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemica...

Read more

09 Sep 202412:00

News

Volumes soar at Jubilant Pharmova Ltd counter

Alembic Pharmaceuticals Ltd, Doms Industries Ltd, EPL Ltd, Anand Rathi Wealth Ltd are amon...

Read more

09 Sep 202414:30

News

Jubilant Biosys signs and issues a put option offer to Pierre Fabre Laboratories

Jubilant Biosys Innovative Research Services,, Singapore (JBIRSPL), subsidiary of Jubilant...

Read more

16 Aug 202418:41

News

Volumes soar at Jubilant Pharmova Ltd counter

Firstsource Solutions Ltd, Adani Energy Solutions Ltd, Sapphire Foods India Ltd, Lloyds Me...

Read more

01 Aug 202414:30

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

PPT

May 2024

PPT

Feb 2024

PPT

Oct 2023

PPT

July 2023

PPT

May 2023

PPT

Feb 2023

Transcript

Aug 2022

Transcript

June 2022

Transcript

Mar 2022

PPT

Jan 2022

Transcript

July 2021

Transcript

June 2021

TranscriptPPT

Jan 2021

Transcript

Nov 2020

Transcript

Sep 2020

Transcript

June 2020

TranscriptPPT

Jan 2020

Transcript

FAQ's For Jubilant Pharmova Ltd Quarterly Result

What is the EPS of Jubilant Pharmova Ltd stock?

The Earnings Per Share (EPS) of Jubilant Pharmova Ltd is 18.13. An EPS is the amount of net income attributed to each share of a common stock.

How is Jubilant Pharmova Ltd EPS calculated?

The EPS of Jubilant Pharmova Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Jubilant Pharmova Ltd report its EPS?

Jubilant Pharmova Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Jubilant Pharmova Ltd EPS?

Factors that influence the EPS of Jubilant Pharmova Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Jubilant Pharmova Ltd EPS growth indicate future performance?

Yes, consistent growth in Jubilant Pharmova Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*